Insider: MORTIMER IAN PRESIDENT & CEO - Xenon Pharmaceuticals Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 19,923 | 14,300 | 34,223 |
| Value | $1,132,622.55 | $812,955.00 | $1,945,577.55 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/13/2026 | DDS | 7,308 | Direct | COM | $55.23 | $403,584.30 | 19,923 |
| 03/10/2026 | DDS | 11,269 | Direct | COM | $60.11 | $677,357.05 | 14,731 |
| 03/09/2026 | DDS | 21,515 | Direct | COM | $60.49 | $1,301,442.35 | 6,000 |
| 03/09/2026 | DDS | 21,791 | Direct | COM | $58.81 | $1,281,528.71 | 59,209 |
| 03/09/2026 | DDS | 10,072 | Direct | COM | $60.47 | $609,053.84 | 8,449 |
| 03/09/2026 | DDS | 31,694 | Direct | COM | $59.88 | $1,897,836.72 | 27,515 |
| 03/09/2026 | DDS | 12,479 | Direct | COM | $59.50 | $742,500.50 | 18,521 |
| 03/09/2026 | DDS | 2,449 | Direct | COM | $61.26 | $150,025.74 | 6,000 |
| 03/09/2026 | DDS | 61,652 | Direct | COM | $60.08 | $3,704,052.16 | 6,000 |
| 03/09/2026 | DDS | 65,000 | Direct | COM | $62.06 | $4,033,900.00 | 6,000 |
| 03/09/2026 | DDS | 43,348 | Direct | COM | $59.26 | $2,568,802.48 | 72,652 |
| 01/02/2026 | DDS | 37,938 | Direct | COM | $44.40 | $1,684,447.20 | 8,062 |
| 01/02/2026 | DDS | 2,062 | Direct | COM | $44.93 | $92,645.66 | 6,000 |
| 12/08/2025 | DDS | 8,820 | Direct | COM | $45.59 | $402,103.80 | 8,010 |
| 12/08/2025 | DDS | 2,010 | Direct | COM | $46.32 | $93,103.20 | 6,000 |
| 12/05/2025 | DDS | 14,375 | Direct | COM | $45.03 | $647,306.25 | 16,830 |
| 11/28/2025 | DDS | 97 | Direct | COM | $45.01 | $4,365.97 | 31,205 |
| 10/01/2025 | DDS | 25,000 | Direct | COM | $40.16 | $1,004,000.00 | 31,302 |
| 01/27/2025 | DDS | 15,166 | Direct | COM | $40.46 | $613,616.36 | 31,302 |
| 01/27/2025 | DDS | 1,149 | Direct | COM | $41.07 | $47,189.43 | 31,302 |
| 01/24/2025 | DDS | 22,468 | Direct | COM | $40.20 | $903,213.60 | 31,302 |
| 01/23/2025 | DDS | 16,217 | Direct | COM | $40.08 | $649,977.36 | 31,302 |
| 05/24/2023 | DDS | 17,069 | Direct | COM | $41.44 | $707,339.36 | 24,213 |
| 05/24/2023 | DDS | 13,179 | Direct | COM | $41.37 | $545,215.23 | 27,708 |
| 05/24/2023 | DDS | 1,407 | Direct | COM | $41.49 | $58,376.43 | 31,302 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research